07 November 2023
James Barder, sits down with David Ridley at Citeline Commercial and shares his thoughts on the fantastic progress at Futura Medical has been making over the past year and its plans for the future.
06 October 2023
James Barder, shares his thoughts with @Megan Thomas in @Drug Discovery World's Fall Issue 2023 on "Where is the drug discovery expertise happening in the UK”
16 July 2023
Futura Medical’s planned rapid growth strategy profiled in the Sunday Times’ Share Tips by Lucy Tobin
06 July 2023
Shares Magazine’s Martin Gamble provides an overview of Futura Medical’s significant innovation in the erectile dysfunction market, following the FDA approval of MED3000
05 July 2023
HBW’s David Ridley provides an outline and his thoughts on the launch of MED3000 in the UK under the Eroxon brand
14 February 2023
HBW’s David Ridley discusses how Cooper Consumer Health is aiming to market Futura's drug-free OTC Eroxon erectile dysfunction gel on European shelves in the next few months
31 August 2022
UK Investor magazine article by Andrew Hore highlighting Futura Medical’s positive news of its Phase 3 clinical study for MED3000.
31 August 2022
Labiotech article by Liza Laws covering Futura Medical’s positive results from its Phase 3 clinical study, FM71, for its breakthrough, fast acting gel, MED3000 for the treatment of erectile dysfunction.
26 May 2022
HBW article Futura Pens Deal With Cooper To Launch Erectile Dysfunction Gel In Europe
23 May 2022
BioWorld article Futura agrees to licensing deal to commercialize ED product in UK & Europe
05 January 2022
Futura article in HBW: Study Suggests Futura’s Drug-Free Erectile Dysfunction Gel Suitable For US OTC Pathway
01 June 2020
NIcholas Hall CHC Insight MED3000 Article
15 February 2020
Futura Medial featured in The Mirror
12 August 2019
Futura Medical featured in Investors Chronicle
20 June 2019
Futura Medical featured in Investors Chronicle
20 March 2019
Futura Medical featured in Master Investor
14 February 2019
Futura Medical's lead product MED2005 featured in Pharmaceutical Technology
31 January 2019
Investors Chronicle
08 January 2019
Growth Company Investor